We are live on
!
Find out more
PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.08B
1-Year Est. Return
29.51%
This Fund
S&P 500
This Quarter
Est. Return
+6.76%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.38B
AUM Growth
+$66.8M
(+2%)
Cap. Flow
-$73.5M
Cap. Flow
% of AUM
-2.18%
Top 10 Holdings %
Top 10 Hldgs %
25.62%
Holding
354
New
31
Increased
99
Reduced
136
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procore
PCOR
|
+$38M |
| 2 |
Flutter Entertainment
FLUT
|
+$31.6M |
| 3 |
Synaptics
SYNA
|
+$10.5M |
| 4 |
Aaon
AAON
|
+$8.88M |
| 5 |
Construction Partners
ROAD
|
+$8.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$26.7M |
| 2 |
Ares Management
ARES
|
+$22.4M |
| 3 |
Mastercard
MA
|
+$10.9M |
| 4 |
Visa
V
|
+$10.7M |
| 5 |
Amazon
AMZN
|
+$9.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.46% |
| 2 | Financials | 15.72% |
| 3 | Healthcare | 15.15% |
| 4 | Consumer Discretionary | 13.81% |
| 5 | Industrials | 9.51% |
Similar funds
CAM
VBA
MRCP
ECP
HCM
DCM
TCG
CLG
Peregrine Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Peregrine Capital Management held 354 positions worth $3.38B, up 2% from $3.31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Peregrine Capital Management's Q4 2024 filing shows 31 new, 99 increased, 136 reduced and 24 closed positions. Its largest new stake was Procore: 535,699 shares worth $40.1M. The largest sale was Edwards Lifesciences, an estimated $26.7M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Peregrine Capital Management's largest Q4 2024 buy was Procore: 535,699 shares worth $40.1M.
- Peregrine Capital Management added most to Synaptics in Q4 2024, an estimated $10.5M increase.
- Peregrine Capital Management's biggest Q4 2024 reduction was Ares Management, cutting an estimated $22.4M.
- Peregrine Capital Management fully exited Edwards Lifesciences in Q4 2024, selling an estimated $26.7M.
- Peregrine Capital Management's ten largest holdings make up 26% of its $3.38B portfolio in Q4 2024.
- Peregrine Capital Management opened 31 new positions and closed 24 in Q4 2024.
- Peregrine Capital Management's portfolio value rose 2% quarter-over-quarter to $3.38B.
Based on Peregrine Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.